Business Wire

Masimo Announces FDA Clearance for Neonatal RD SET ® Pulse Oximetry Sensors with Improved Accuracy Specifications

Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...
Nasdaq

Masimo's Neonatal RD SET Pulse Oximetry Sensors Get FDA Nod

Masimo Corporation MASI received the FDA’s nod for its RD SET sensors to be used with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry. The procedure is aimed at offering improved ...
Business Wire

Masimo Monitoring Solutions Promote Newborn and Maternal Safety

New Neonatal Study Adds to Body of Clinical Evidence Demonstrating Masimo SET ® Pulse Oximetry’s Unique Ability to Improve Care NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) provides ...
Medindia

Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors

Smaller, Flexible Sensors Are More Comfortable for Patients, Easier to Apply for Clinicians "Masimo's new low-profile sensors are not only flatter and easier to apply, but the added pliability allows ...
Nature

Reflectance Pulse Oximetry from Core Body in Neonates and Infants: Comparison to Arterial Blood Oxygen Saturation and to Transmission Pulse Oximetry

However, the traditional method of transmission pulse oximetry (TPO) has several limitations. In conditions of poor peripheral perfusion or cardiovascular collapse, the measurements of this method are ...
Nasdaq

Masimo Announces FDA Clearance for Neonatal RD SET® Pulse Oximetry Sensors with Improved Accuracy Specifications

Masimo’s revolutionary SET® pulse oximetry has been shown in more than 100 independent and objective studies to outperform other pulse oximetry technologies – even before the revisions that achieved ...